Teleflex Incorporated (NYSE:TFX) Shares Sold by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP cut its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 61.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 106,304 shares of the medical technology company's stock after selling 170,713 shares during the quarter. ExodusPoint Capital Management LP owned approximately 0.23% of Teleflex worth $18,920,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in TFX. Headlands Technologies LLC purchased a new stake in Teleflex in the fourth quarter worth $29,000. Avior Wealth Management LLC boosted its stake in Teleflex by 81.2% during the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after purchasing an additional 125 shares during the last quarter. IFP Advisors Inc increased its holdings in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after buying an additional 217 shares in the last quarter. Exchange Traded Concepts LLC raised its holdings in shares of Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after purchasing an additional 94 shares during the last quarter. Finally, R Squared Ltd purchased a new stake in Teleflex during the 4th quarter valued at $64,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Trading Up 6.4 %

Shares of Teleflex stock traded up $8.15 during mid-day trading on Wednesday, hitting $135.29. The stock had a trading volume of 1,274,176 shares, compared to its average volume of 608,978. The firm has a market cap of $6.27 billion, a P/E ratio of 26.90, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a 12-month low of $124.66 and a 12-month high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The firm has a 50-day moving average of $149.82 and a two-hundred day moving average of $183.14.

Teleflex (NYSE:TFX - Get Free Report) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were given a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.01%. Teleflex's dividend payout ratio (DPR) is presently 95.77%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on TFX shares. Morgan Stanley lowered their price target on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a report on Wednesday, March 5th. Citizens Jmp cut shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. Piper Sandler restated a "neutral" rating and issued a $140.00 target price (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Wells Fargo & Company decreased their price target on Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Teleflex currently has a consensus rating of "Hold" and a consensus price target of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.